Unit of Endocrinology, University Hospital Brasilia, University of Brasilia, Brasilia, Brazil ; CLINEN - Clínica de Neurologia e Endocrinologia. SCN quadra 1, bloco F, Ed. America Office Tower, sala 1111, Brasília, DF 70711-905 Brazil.
Dipartimento di Scienze Farmacologiche e Biomolecolari, Sezione di Biomedicina ed Endocrinologia, Università di Milano, Milan, Italy.
Diabetol Metab Syndr. 2015 Jul 22;7:65. doi: 10.1186/s13098-015-0057-9. eCollection 2015.
To determine whether cortisol secretion and glucocorticoid receptors in lymphocytes and monocytes are altered in patients with impaired glucose tolerance, and whether treatment with a hypocaloric diet and metformin could interfere with these aspects.
This is an analytical, interventional, case series study. Patients with impaired glucose tolerance were included. They received 500 mg of metformin twice daily and followed a low glycemic index diet for 16 weeks. Cortisol levels were assessed at 8:00 A.M. before and after use of 0.25 mg of dexamethasone at 11:00 P.M. the day before.
Sixteen subjects (9 men) were included. Normal basal levels of cortisol and adequate responses to the low dose of dexamethasone were observed before and after treatment. There was no significant correlation between the parameters evaluated and cortisol levels. Nevertheless, there was a strong correlation between the number of glucocorticoid receptors, BMI (r = 0.88; p = 0.02), and insulin AUC (r = 0.94; p = 0.005) before treatment; after treatment, all these associations ceased to exist.
The cortisol secretion remained normal in the group of patients with impaired glucose tolerance. Treatment with metformin and diet did not change this condition. However, glucocorticoid receptor number had a strong correlation with insulin, due to insulin resistance, but this characteristic was lost after treatment.
为了确定葡萄糖耐量受损患者的淋巴细胞和单核细胞中的皮质醇分泌和糖皮质激素受体是否发生改变,以及低热量饮食和二甲双胍治疗是否会对此产生影响。
这是一项分析性、干预性、病例系列研究。纳入葡萄糖耐量受损的患者。他们每天接受两次 500 毫克二甲双胍治疗,并遵循低升糖指数饮食 16 周。在使用 11:00 P.M. 前一天 0.25 毫克地塞米松前和后,于上午 8:00 评估皮质醇水平。
纳入 16 名受试者(9 名男性)。治疗前后均观察到正常的基础皮质醇水平和对低剂量地塞米松的充分反应。评估的参数与皮质醇水平之间没有显著相关性。然而,在治疗前,糖皮质激素受体数量与 BMI(r=0.88;p=0.02)和胰岛素 AUC(r=0.94;p=0.005)之间存在很强的相关性;治疗后,所有这些关联都消失了。
葡萄糖耐量受损患者的皮质醇分泌保持正常。二甲双胍和饮食治疗并未改变这种情况。然而,由于胰岛素抵抗,糖皮质激素受体数量与胰岛素之间存在很强的相关性,但在治疗后这种特征消失了。